The physician gender pay gap eased from 28% in 2021 to 26% in 2022.
After increasing 3.8% in 2021, the average pay for doctors last year decreased 2.4%, according to Doximity survey data released today.
More than 80% of doctors are members of Doximity, a digital platform for U.S. medical professionals. The annual physician compensation report released today is based on survey data collected from more than 31,000 full-time physicians in 2022.
The Doximity report features several key findings:
Doximity found a significant gender pay gap among physicians, with male doctors earning $110,000 more than their female counterparts. This represents a 26% gender pay gap in 2022, compared to a gender pay gap of 28% in 2021.
Physician compensation growth in metropolitan areas decreased in 2022. In 2021, the top 10 metropolitan areas for physician compensation growth experienced growth rates of at least 6%. In 2022, Oklahoma City, Oklahoma, was the only metropolitan area with a physician compensation growth rate above 6%.
Emergency medicine led all specialties in compensation growth (6.2%) followed by pediatric infectious disease (4.9%) and pediatric rheumatology (4.2%).
Charlotte, North Carolina ($430,890), St. Louis, Missouri ($426,370), and Oklahoma City, Oklahoma ($425,096) were the metropolitan areas with the highest average compensation.
Washington, DC ($342,139), Baltimore, Maryland ($346,260) and Boston, Massachusetts ($347,553) were the metropolitan areas with the lowest average compensation.
The specialties with the highest average annual compensation tended to be surgical and procedural specialties treating adults. The top three specialties by average annual compensation were neurosurgery ($788,313), thoracic surgery ($706,775), and orthopedic surgery ($624,043).
The specialties with the lowest average annual compensation tended to be pediatric and primary care specialties. The bottom three specialties by average annual compensation were pediatric endocrinology ($218,266), pediatric infectious disease ($221,126), and pediatric rheumatology ($226,186).
Most physicians have either accepted lower compensation for more autonomy or better work-life balance (35%) or would consider lower compensation for more autonomy or better work-life balance (36%).
Interpreting the data
Compared to 2021, physician compensation growth was low in 2022, the Doximity report says. "In 2021, there was an increase in compensation across all specialties. However, in 2022, compensation was stagnant or down across many specialties, contributing to the overall decline observed across the industry. Emergency medicine physicians reported the highest increase in compensation in 2022, a likely result of the continued demand for emergency healthcare services."
Several factors likely contributed to the decline in average compensation in 2022, Amit Phull, MD, senior vice president and medical director of Doximity, told HealthLeaders. "What we have found is that the reimbursement mix is changing over time. In addition, physicians have been negotiating down their compensation in return for better control over their work-life balance and greater autonomy. In addition, physicians have been taking on more hybrid careers. All of this has come together to result in a slight decline in compensation."
He had mixed views on the long-term prospects for the physician gender pay gap. "The optimist in me would like to think that over time the gender pay gap will close. There was a slight reduction that we found year-over-year from 2021 to 2022. The cynic in me would focus more on the fact that despite that slight reduction, the pay gap itself is still quite substantive. The last time we looked at rolling out the pay gap across a career, it netted out to a couple of a million dollars in compensation over the course of a clinical career."
Providing female physicians with compensation data could help reduce the gender pay gap, Phull said. "Part of why we do a physician compensation report is we view it as a service for our members. For the female cohort of Doximity members, if they are made aware of the pay gap, they might be empowered to be better advocates for themselves. I am cautiously optimistic that the gender pay gap can be reduced."
Autonomy and work-life balance have clearly become important factors for physicians, he said. "Physicians are people, too. So, autonomy and work-life balance are generally important, and given the events that have transpired over the past few years, autonomy and work-life balance have been amplified even further. That reality that we lived through during the pandemic is an accelerant on a trend that already existed in the healthcare space. Over the course of the last generation of physicians, the ability to manage your own practice has changed substantively. … This is just the beginning of more interest in life-work balance. We have begun to see signs of overwork and burnout present themselves more consistently."
Mental health conditions have come to the forefront in the United States for all age groups.
Addressing mental health needs is a primary aspect of healthcare in the post-COVID world, the new chief medical officer of MSU Health Care says.
Michael Weiner, DO, MSM, was named the new CMO of MSU Health Care, in East Lansing, Michigan, last month. Prior to joining MSU Health Care, he served as CMO for Maximus, a public company that contracts with government agencies to make them more accessible and affordable. He was previously chief medical information officer at IBM, where he led the healthcare solution teams in infrastructure, analytics, consumer engagement, and cognitive computing. Previously, as both CMO and CMIO for the U.S. Department of Defense, his office was responsible for a significant enhancement to the Veterans Affairs electronic medical record.
HealthLeaders recently spoke with Weiner about a range of topics, including clinical challenges now that the crisis phase of the coronavirus pandemic has passed, electronic medical records, and physician leadership. The following transcript of that conversation has been edited for clarity and brevity.
HealthLeaders: Now that the crisis phase of the pandemic has passed, what are the primary clinical challenges that health systems are facing?
Michael Weiner: The tsunami that is coming our way post-COVID revolves around the mental health needs of the populations that we serve. People are going to start reaching out for the mental health support that they have come to realize that they need, whether that be loneliness, depression, or anxiety. These topics have all come to the forefront of care in America today across all age groups.
Post-COVID, we are going to have a focus on mental health. We are fortunate to have an amazing mental health department at MSU Health Care that we look forward to relying on to support this burgeoning population of patients who have increased mental health and behavioral health needs.
HL: What do you anticipate will be your biggest challenges in serving as CMO of MSU Health Care?
Weiner: The challenges for the CMO at Michigan State University are the same challenges that are affecting medicine in 2023 across the nation. There are increasing patient needs, decreasing provider resources, technology is being added to the mix, there is more and more provider burnout, and we are all living in a post-COVID world.
On the patient side, we are seeing an increased need for mental health services and an aging population. We are seeing shrinking resources to support those populations and are layering more technology into the provider workflows that is increasing burnout even further.
HL: How can a CMO rise to these challenges?
Weiner: We need to address these challenges one-by-one. There is nothing we can do about the changing demographics of aging populations that come with more diabetes, more obesity, more hypertension, and more mental health needs. We just need to understand that these patients are coming, and we need to support them. We may not have control over this challenge, but we do have control over what we can do and offer to the populations that have entrusted their care to us. We can make sure we have the right tools, the right people, and the right teams to support them.
We need to get to the root causes of burnout for our providers and our support staff. Like anything else in the world, burnout is a complex mix of factors. We were already looking at provider burnout pre-COVID, then COVID caused even higher degrees of provider burnout, and we lost providers throughout the pandemic. So, our goal is to build the pool of providers back up. We are actively recruiting providers to come and join our team. Our goal is to make MSU Health Care the place to work in America.
HL: How will your experience serving as CMIO at IBM help you in your new role at MSU Health Care?
Weiner: Burnout is tied to many of the new technologies that have been given to our providers. If you look at the core of that, there is an electronic health record that was mandated years ago, and many providers are skeptical that EHRs were created with them in mind.
What I was able to learn at IBM is that there are many new technologies emerging in support of better patient care, better quality care, and increasing access to care. If we go back to the concerns about providers, how do we make the electronic health record experience better for our providers and staff? We cannot forget our nurses and medical assistants who are all interacting with the same technology and have had many of the same frustrations. We need to concentrate on technology to make that experience better.
We have learned there are things we can put into the system such as voice recognition technology integrated with our electronic health record to improve the workflow of seeing a patient. Right now, our job is to listen to the providers, hear what they are asking for, and begin to deliver to improve their experience. If we can take good care of our staff, that allows our staff to take amazing care of our patients.
Michael Weiner, DO, MSM, chief medical officer of MSU Health Care. Photo courtesy of MSU Health Care.
HL: How will your experience enhancing the EHR at Veterans Affairs help you in your new role at MSU Health Care?
Weiner: While working at the Department of Defense and working with the VA, I had the opportunity to serve large populations of providers—thousands of providers. After a while, you begin to realize the challenges for providers are common regardless of where they are practicing care. Whether a provider is working at the VA or an academic medical center, the challenges are largely the same.
I have been able to take lessons learned at the VA and bring them to this incredible academic medical center. With this experience, I am hoping to achieve progress more quickly.
The one thing we worked on at the VA and are hoping to bring here is optimization, which becomes a life-long journey in whatever electronic health record you are using. The electronic health records are typically developed with teams of experts and users of the system—we call them "super users" who are high-end users. We want to be able to take the lessons that the electronic health record vendors have built into their systems and bring those across to our own providers, so they can be more efficient, optimize the way the system is used, be able to document more quickly, spend more time with patients, and get home at a reasonable time.
HL: Is there anything specific that can be done to electronic health records to make them more user friendly for clinicians?
Weiner: You must aim for optimization of the electronic health record. For example, when I see a patient, if I have to click 40 times to get from the beginning of the patient encounter to the end of the patient encounter, is there a more optimal way to do that? Is there a way to get through in 20 clicks? Is there a way for me to be able to dictate into the blocks I need to fill out to make it more efficient for me?
One solution is advanced optimization training, which is having elbow-to-elbow experts working with the physicians as they see patients to improve their workflow within the electronic health record. There are also technologies that can make the experience better for clinicians and patients. We have adopted patient-supportive technology to make it easier to sign in, to make it easier to give medical history, and to avoid filling out pages of forms when you see a doctor. You can also bring in additional support such as scribes to help do the input work. We are looking at optimizing the electronic health record to improve retention and to make us a more attractive employer.
HL: You have a clinical background in internal medicine. How will this clinical background help you serve as CMO of MSU Health Care?
Weiner: I believe that primary care is the basis of care for a population. I am a primary care physician, and being able to support patients holistically in their journey through the healthcare system is invaluable in helping to elevate the health of an entire population.
Serving as a primary care physician helps me serve as CMO. It gives me an understanding of the care of a population and an understanding of my primary care colleagues who provide care to patients who seek care at Michigan State University. It also has involved years of interacting with specialty care providers who also support our patients. So, I know the primary care side and have worked with specialty care providers for two decades, and this will help me bring us together as a tightly knit team.
HL: What are the primary keys to success in physician leadership?
Weiner: At the nd of the day, providers have three requests of their leadership.
Number one, they want to be listened to. They want someone to hear them. Providers do incredible work taking care of complex populations, and they have asks. Since I began working here, no one has asked for anything unreasonable given our collective goal of delivering better care.
Number two, they want to be supported. How do we offer them the support that they are asking for?
Number three, they want to work with someone who is also seeing patients. In my role, I am working with patients with a full clinic schedule.
Those three things make for a good physician leader at a health system, particularly a good CMO.
Hopper Health is serving neurodivergent patients in California and New York.
A new healthcare company has launched a digital-first primary care platform to serve neurodivergent adults.
One in five U.S. adults is neurodivergent, with a range of conditions such as autism, attention-deficit/hyperactivity disorder (ADHD), obsessive compulsive disorder, and Tourette syndrome. These adults can struggle in healthcare settings; for example, dense paperwork can overwhelm them and bright lights can lead to anxiety.
Brooklyn, New York-based Hopper Health is serving neurodivergent adults in California and New York. Hopper CEO and founder Katya Siddall-Cipolla told HealthLeaders that she was inspired to create the company from personal experience.
"I am an autistic and ADHD person myself, and I also have Crohn's disease, which is a lifelong chronic illness, and I have spent the past 20 years of my adult life not getting medical care that understands people like me. Whether it is not understanding my sensory needs in a medical environment or communicating differently the way that I might explain or experience pain, I have gotten care that sometimes was not the right care or sometimes was delayed by many years. … For me, the inspiration for Hopper is I do not want my daughter's generation to go through the things that my generation has had to go through to get to some semblance of health," she said.
Siddall-Cipolla said there are two primary elements to providing quality care for neurodivergent adults.
"One is clinicians understanding the population, being very curious, being collaborative with patients, and understanding that they must take time and energy to deeply understand what is going on because if they operate at the surface level, oftentimes they might miss cues that neurodivergent people are sending that are important from a diagnostic perspective. The other piece that is incredibly important is the peer support component. Many neurodivergent folks like myself struggle with executive functioning—things like planning, task follow-through, and following steps in a certain order. So, the red tape of healthcare such as insurance, specialist visits, and who is in network and out of network is so challenging that oftentimes people like me will just avoid care and shut down. The peer navigation component is designed to be the support system for health for the individual patient," she said.
Clinicians selected to cater to neurodivergent adults
Hopper clinicians offer culturally competent care, Siddall-Cipolla said. "One thing we have done is we want to be neurodivergent-affirming, which means we need to understand the experience of neurodivergent people. We need to be thoughtful of sensory needs, information processing, and communication differences. In addition, all of our providers go through a training process for people of color as well as LGBTQ and transgender issues so that they have a broader perspective on inclusion. Unfortunately, there are a lot of neurodivergent folks who are multiply marginalized, and they have the least access to care and tend to have the lowest success rates finding clinicians who can understand them."
Hopper offers contextual primary care, she said. "Context is the patient's environment and experience—it is what is happening with them. We are saying that we are meeting people where they are instead of expecting them to come to where we are. We are wanting to understand all of the context around a person's experience, so that we can accommodate them appropriately in a healthcare setting, versus saying, 'This is how you must show up. This is how you must access care. This is our process.'"
Peer navigators
Peer navigators are a key aspect of Hopper, Siddall-Cipolla said. "Our navigators have been through health challenges. Our navigators have dealt with the mental health system. Our navigators live challenges every day, and they also have the additional education around the healthcare ecosystem as well as how all the parts and pieces fit together at a level that most patients do not have."
The navigators can help neurodivergent patients with tactical healthcare challenges such as prior authorization for medication as well as other issues, she said. "They can also help with things like asking for accommodations at work, or things like getting an MRI. For patients who have never had an MRI, our navigators can tell the patients about accommodations they can reasonably ask for at the imaging center. Navigators can call ahead and have conversations with office staff for other types of visits to make sure our patients are understood even before they walk in the door. They do advocacy work on top of the navigation component."
Visit length and financial model
At Hopper, telehealth visits are usually longer than typical primary care visits, Siddall-Cipolla said. "Our first 'welcome' visit with each patient is a full hour with their primary care provider. Prior to that full hour, patients have an opportunity to connect with their navigator, talk through some of their challenges, and give more context. So, by the time the patient sits down with the clinician, the clinician has a ton of contextual information about the patient's life, and the clinician has time to ask questions. … A typical urgent care visit is anywhere from 20 to 30 minutes, depending on the issues. There is time with the patient and time for good charting and documentation as well as follow-up."
For now, Hopper is operating with a direct-to-consumer financial model, with patients joining monthly or annually. The monthly fee is $99. Hopper hopes to establish relationships with payers soon, she said. "The near-term goal is to be in a capitated model with payers. We want to offer true value-based care and take on risk for managing our patients' conditions."
Overdoses, particularly involving opioids, are a national crisis, according to the Centers for Disease Control and Prevention (CDC). There were an estimated 107,622 drug overdose deaths in 2021, an increase of nearly 15% from 2020.
The ability to provide buprenorphine for opioid withdrawal in emergency departments is a gigantic leap forward in substance use disorder care, says Natasha Kolb, MD, emergency medicine program medical director at Presbyterian Medical Group.
"Historically, when we would see patients in the emergency department in opioid withdrawal, we would give them medications to try to cover up the symptoms of withdrawal and they were suboptimal. You would give a patient something for nausea and it would help a little bit, but nothing we gave them helped with the craving for opioids. Now, while a patient is in the ED and in crisis, we can start them on a medication that not only treats the symptoms of withdrawal but also treats the craving for opioids. So, they leave the ED feeling normal and they are more likely to follow through on appointments to get continued prescriptions for buprenorphine or make it to an inpatient treatment center or outpatient care. The success rates went way up to keep people in treatment," she says.
Providing naloxone for opioid overdose
In addition to providing buprenorphine in PHS emergency departments, the health system is dispensing naloxone to patients as well as family members in EDs, Kolb says. "What we do when a patient is in the ED and has suffered a near-death experience because they have overdosed on an opioid, we actually put a Narcan atomizer in their hand or the hand of a family member. We say they have something that can save their life if there is another overdose, and they walk out of the ED with that life-saving medication. It is part of their ER visit, they do not have to pay for it, and they do not have to go to a pharmacy to fill a prescription."
Filling a prescription for naloxone at a pharmacy can be daunting, she says. "It can be difficult to fill a prescription for naloxone. If you go to the pharmacy to fill the prescription, the cost is $90 with insurance."
Interdisciplinary approach
PHS emergency departments are providing evidence-based treatment for opiate and alcohol use disorder through an interdisciplinary workgroup that includes peer support specialists, pharmacists, informaticists, addiction specialists, and emergency medicine clinicians, Kolb says.
The peer support specialists are crucial, she says. "We have peer support specialists—many of them were formerly addicted to substances themselves and are in recovery. So, they are the perfect people to connect with patients, and they work in our EDs. They get a list of patients who have checked in with certain acute complaints such as withdrawal, then they talk with the patients; and if we initiate treatment, they will circle back with the patient within 24 hours to see how the patient is doing. They help patients with the next step to get treatment in an inpatient or outpatient setting. They also come to our interdisciplinary meetings on substance use disorder."
The pharmacists are also key members of the interdisciplinary team for substance use disorders, Kolb says. "Pharmacy has also been critical in coming to these meetings, too. They talk about stocking naloxone, so we have it in our drug cabinets to dispense. They make sure we have the right formulations of buprenorphine—is it going to be a pill or is it going to be the dissolvable strips?"
Opioid stewardship
PHS emergency departments practice opioid stewardship to reduce addiction to opiates, she says.
"We have worked on making our order sets to take providers to non-opioid pain management strategies first, then work down to opioids as the last option. It's not that we never use opioids—if there is a bone sticking out of a patient's leg, you are probably going to have to use morphine for that patient. But we try to start at the safest and easiest modalities first. So, you start at the top of the order set with old-school therapies such as ice or a heat pad, then you might go to topicals such as patches with lidocaine for someone with back pain. Then you move to non-opioid medications such as acetaminophen and ibuprofen. Opioids are used as the last resort."
PHS hospitals are also using technology to promote opioid stewardship, Kolb says. "If a provider writes a prescription for a patient to go home with an opiate, our electronic medical record is integrated with our Prescription Monitoring Drug Program system. So, when a provider wants to write a prescription, you get a pop up with a link to the patient's prescription history. If there is any indication that the patient is not using opioids in a safe manner, the provider gets that information before the prescription is written."
CommonSpirit Health has launched several efforts that target cardiovascular care in maternal health.
CommonSpirit Health is stepping up efforts to address cardiovascular disease in maternal health.
In several reports, the United States has the highest maternal mortality rate compared to other developed countries—a report from The Commonwealth Fund found the United States had the worst maternal mortality rate compared to 10 other developed countries. According to a Centers for Disease Control and Prevention (CDC) report, the U.S. maternal mortality rate rose from 20.1 deaths per 100,000 live births in 2019 to 23.8 in 2020. The CDC report highlighted a racial disparity, with the maternal mortality rate for Black women at 55.3 deaths per 100,000 live births, which was nearly three times higher than the rate for White women.
A new report from the CDC shows that the U.S. maternal mortality rate rose 40% from 2020 to 2021.
Addressing cardiovascular disease during pregnancy is crucial to reducing maternal mortality, says Rachel Bond, MD, system director of women's heart health at CommonSpirit. "Cardiovascular death, which is the leading cause of death during pregnancy, is preventable 80% of the time. A lot of that has to do with us communicating with each other and diagnosing these conditions early."
CommonSpirit has established a Maternal Heart Council to educate patients and clinicians about cardiovascular health during and after pregnancy as well as to provide guidance and protocols, she says. "We are getting guidance from both cardiologists who specialize in high-risk pregnancies as well as cardiologists from subspecialty services. So, in the event that we need interventional cardiologists, advanced heart failure cardiologists, or cardiologists who come from other specialties such as electrophysiology where we may have an abnormal heart rhythm, they are incorporated within the Maternal Heart Council. We work collaboratively with the primary obstetrician as well as the maternal fetal medicine provider, who is a high-risk obstetrician."
The Maternal Heart Council is led by physicians and includes advanced practice providers, nurses, and hospital administrators, Bond says. "We all work collaboratively, and the council meets monthly. In addition to the council, on the outskirts of the council, clinicians and nurses meet regularly to actively discuss the day-to-day management of individual patients. So, the council is a broader umbrella, where we are creating guidance on protocols and educational materials that we give to both patients and clinicians. Outside the scope of the council, we as clinicians are meeting regularly and discussing these patients."
Targeting preeclampsia
CommonSpirit has also developed quality improvement toolkits to address preeclampsia, she says. "We know that preeclampsia is an independent risk factor for cardiac disease, which may occur during a pregnancy but can also occur decades after a pregnancy. This is why we like to target preeclampsia because it is a common adverse pregnancy outcome that we are seeing and rates of it are increasing. A lot of that has to do with the fact that women are having children later in life, and we know that anyone who has a baby past the age of 35 is at a slightly higher risk of having preeclampsia. The other reason we are focusing on preeclampsia is that many of these moms are coming into pregnancies with many common risk factors for high blood pressure outside the scope of pregnancy, and preeclampsia impacts blood pressure."
The health system is providing education about preeclampsia, Bond says. "The way from a quality improvement perspective we have been able to tackle preeclampsia is by providing education not only to the patients but also to the clinical staff. The way we have been able to do this successfully for the patients is we have created a 'passport.' That passport goes over signs and symptoms of how preeclampsia may present. It also goes over the common risk factors. In addition, it goes over how to track your blood pressure during pregnancy and after pregnancy. One thing many people do not realize is that when it comes to preeclampsia, it can occur in the post-partum period, usually upto six weeks post-partum."
Providing preeclampsia education to clinicians is pivotal, she says. "The first group of clinicians preeclampsia patients are seeing when they come to the hospital are emergency physicians. So, there is a large value in educating our emergency room providers. One of the questions we have them ask is, 'When was your last pregnancy?' If your last pregnancy was within a year, and you are coming in with signs and symptoms that are concerning for a cardiac condition, it could be related to that pregnancy. We have come a long way in providing education to our emergency medicine providers; and, similarly, we have provided education to our inpatient internal medicine providers—our hospitalists. It is important to highlight that this education is not just in the inpatient setting, it is also in the ambulatory setting. That is where this education has been targeting our obstetricians."
Standardizing care and protocols
Standardizing care and protocols for maternal health is essential, Bond says. "Data has shown that standardizing care and standardizing protocols can ensure that all of our patients are receiving the same level of care. More importantly, standardizing care and standardizing protocols can ensure that patients have access to the most current research and best practices."
Standardizing care and protocols helps address disparities in maternal health, she says. "It is important to highlight the fact that we have a maternal health crisis in the United States, and we know that this crisis disproportionately is affecting women of color and women who come from lower socioeconomic status. Unfortunately, one driver of this situation is there is implicit bias. So, if we remove the potential for implicit bias by standardizing care and creating protocols that are available for anybody regardless of race, ethnicity, or socioeconomic status, our hope is that we will be able to make a change and decrease poor outcomes."
Virtual care for rural patients
To help reach patients who struggle with healthcare access, CommonSpirit is providing virtual care for rural patients, Bond says. "We are targeting rural areas for telemedicine because we know those areas are where we have the majority of maternal care deserts. A maternal care desert is where you have limitations in obstetric care. Not only do they have limitations in obstetric care, but they also have limitations in specialty care such as cardiologists who focus on high-risk pregnancies."
Using telemedicine for patients in rural areas is good for patients and clinicians, she says. "It has been phenomenal because it allows us to reach the patient, it is convenient for the patient, and it can be convenient for clinicians. Through these visits, patients can access all levels of care that they may not already have available in their communities. More importantly, we can work with physicians who are more local to the patient to try to provide them guidance and co-manage patients."
At Pfizer, a global approach to supply chain is crucial, one of the company's senior vice presidents says.
In the U.S. pharmaceutical sector, supply chain resiliency is not achieved through concentrating all manufacturing capabilities in the country, a top Pfizer executive said yesterday during a webcast held by The Brookings Institution.
Supply chain resiliency has been a hot topic during the coronavirus pandemic. Shortages of medical supplies and medications such as personal protective equipment have sparked debate on whether more medical products should be produced domestically.
Pfizer's capacity to produce an unprecedented supply of COVID-19 vaccine in a short period of time was the result of a global supply chain, not just investments in the United States and Europe, said Tanya Alcorn, senior vice president as well as biotech and sterile injectables operations lead at Pfizer.
"In order to make those vaccines, we needed hundreds of materials from more than 80 suppliers that were located in about 20 different countries. That is why the idea of onshoring may make us feel better, but it is not the answer. Having agreements that incentivize governments to play together in a fair way to allow for trust and free movement of goods is the way you get to resiliency, not trying to bring everything into one country because one country cannot solve it all," she said.
Pfizer achieves risk mitigation and supply chain resilience through several methods, Alcorn said.
"As a manufacturing organization, we are constantly assessing risk and resiliency. We are assessing risk whether it is war as we have seen in Ukraine or natural disasters. So, we think about risk in a lot of different ways, and we are constantly looking at ways to mitigate risk. We do it through scale, through redundancy of suppliers, through inventory management, and not relying on one supplier in one country. We diversify our supply chain. For us, diversification is key as well as building a trust relationship with suppliers and encouraging governments to allow the free flow of materials," she said.
When it comes to the COVID-19 vaccine, building production facilities in developing countries would not have solved those countries' vaccine access challenges, Alcorn said. "What we have learned through our experience working with developing nations is putting a plant in the country is not the answer. It may make us feel better, but it is not the answer. We have found that one of the primary barriers is infrastructure. So, the infrastructure that surrounds the storage, distribution, and administration of vaccines was more of the barrier."
In some developing countries, Pfizer used drone technology to address the vaccine access challenge, she said. "We created a packaging that allowed our vaccine to be drone shipped and dropped into villages. That is how we expanded access. It was successful versus if we built a plant in the country, which would not have solved the fundamental access problem."
At Pfizer, a global approach to supply chain is crucial, Alcorn said. "Pfizer is all about giving access to as many patients as possible to our medicines and vaccines. The way that we do that is through trust, partnership, and scale. Not one country can do it alone. You need many countries and many partners. You need the private sector and governments all playing nicely together."
Wake Forest Health Network is experiencing workforce shortages of clinical and nonclinical staff.
Workforce shortages are the primary challenge of managing Wake Forest Health Network, the president of the medical group says.
Russell Howerton, MD, is president of the medical group and senior vice president of clinical operations at Atrium Health Wake Forest Baptist. A practicing surgeon, he previously served as chief medical officer of Wake Forest Baptist Health.
Wake Forest Health Network employs about 500 physicians and advanced practice practitioners.
Howerton recently talked with HealthLeaders about a range of issues, including physician engagement, the challenges of serving as senior vice president of clinical operations at Atrium Health Wake Forest Baptist, and clinical care predictions for 2023. The following transcript of that conversation has been edited for brevity and clarity.
HealthLeaders: What are the challenges of leading the Wake Forest Health Network?
Russell Howerton: Emerging from the pandemic, our greatest challenge has been the workforce at either end. Staffing the non-provider workforce and securing adequate resources for our teams to deliver the expectations we have of them has been a great challenge. At the other end, provider recruitment, retention, and burnout have been major factors.
We have learned a great deal and done a great deal to develop our pipelines and recruiting processes for the non-provider staff—clinical and nonclinical, front desk, and the backend. We have always had partnerships with those who produce that element of the workforce, but over the past couple of years, we have had to redouble our focus and intensify our efforts to strengthen those partnerships. We are not the only healthcare entity in the market for those individuals—it is ferociously competitive. We are gaining ground, but we are not where we want to be.
HL: How have you risen to the challenge of recruitment and retention in your provider workforce?
Howerton: There are many components of recruiting physicians and advanced practice practitioners. Of course, striving to have market compensation is always a core tenet—it is necessary, but it is not sufficient. Today, it is our perception that meeting the needs of physicians to feel an appropriate balance of autonomy and being securely nested in a larger system that insulates them from some of the vagaries of business practices is the task. In either direction, you can go off the rails. Certainly, you can insulate them a great deal, but you do not want to become too controlling of their daily lives and clinical activities. We feel we are striking an appropriate balance.
We are not as fully staffed as we would like, and we continue to face challenges recruiting primary care physicians. There are many new entrants and new models in the market, not just our traditional competitors. We have all recently watched primary care models for CVS and Amazon.
Creating the work environment that promotes physician engagement is a retention strategy. We also want to be the best place to work.
HL: What are the primary efforts you have in place to address burnout?
Howerton: You need to ease the barriers to giving good care. As an analogy, part of leadership's job is to make giving clinical care feel like a fish swimming downstream with the tide, not having to swim upriver against the tide simply to deliver the care that your professional standards call you to do. For better or worse, the complexities of modern care delivery and organizational structure manage to put a lot of obstacles in the way of giving clinical care. We are trying to address those obstacles.
Russell Howerton, MD, president of Wake Forest Health Network and senior vice president of clinical operations at Atrium Health Wake Forest Baptist. Photo courtesy of Atrium Health Wake Forest Baptist.
HL: What are the primary elements of physician engagement?
Howerton: Listening is essential, along with conveying that something was heard. When you listen, you will often hear much more than you can address. Physicians express broad concerns from promoting world peace to not having the parking lot swept often enough at a practice. You need to listen, hear, and act whenever possible on as many issues as possible.
HL: You serve as senior vice president of clinical operations. What are the challenges of serving in this role?
Howerton: I am responsible for several business lines and subsidiaries. I help oversee Wake Forest outpatient dialysis—we are the eighth-largest provider of patient dialysis in the nation. We operate more than 20 sites around our part of the state. It's an interesting business. It is like the hospital business in that it requires staff in place every day to care for the patients. Again, we have had an intense challenge of maintaining adequate staff to offer the services we need to provide, and the dialysis population is a non-elective population. They need to have their care whether you have staff or not.
Compared to the physician group, there is a much smaller pipeline of available individuals with knowledge in dialysis. We are using some of the same mechanisms used in large facilities but there are relatively few travelers in the dialysis world. We are actively recruiting overseas even though the lead time to onboard someone from an overseas environment is many months—it is still an overall more favorable investment than travelers.
To rise to this workforce challenge at the dialysis centers, we have adjusted our pay scales and we have broadened our recruitment searches. There is a higher labor cost in the nation today to get dialysis in real dollar terms than there was pre-pandemic. We do not envision that going away. We seek to find efficiencies and improvements in other aspects of the model.
HL: Do you have any clinical care predictions for 2023?
Howerton: I believe we will learn how telehealth will fit into the long-term model of healthcare. It clearly has a place we would not have imagined if you had asked us in January of 2020 before the pandemic.
I predict that the end of the public health emergency and the variety of approaches to the waivers and regulations that have allowed us to adopt a care model during the pandemic will lead to confusion for a couple of years.
HL: You have a clinical background as a surgeon. How has this clinical background helped you serve in physician leadership roles?
Howerton: Surgery requires a leader of a team to get the rest of the team to work together toward a common goal. That leadership skill is generally translatable to administrative leadership roles. I have a personal belief that the currency of leadership is the confidence of those you help lead that you, the leader, has confidence in them to do the job. The daily work of leadership is to build this confidence in those you help to lead, so that when you need to draw upon it, you can, and everyone can succeed.
Inappropriate prescribing of antibiotics for upper respiratory tract infections as well as coprescribing of opioids and benzodiazepines were tied to shorter primary care visits.
Shorter primary care visit time is associated with some inappropriate prescribing decisions, a new research articlefound.
Time is a key factor in primary care, with the average visit lasting 18 minutes. Survey data in previous studies has found that patients often report needing more time in primary care visits and the length of primary care visits is one of the most important factors in patient satisfaction.
The new research article, which was published by JAMA Health Forum, is based on data collected from more than 8 million primary care visits in 2017. The data features visits with more than 8,000 primary care physicians.
The researchers examined three kinds of prescribing decisions: antibiotics for upper respiratory tract infections, coprescribing of opioids and benzodiazepines, and potentially inappropriate prescribing for older adults.
The study includes several key data points:
Longer primary care visits were associated with more complex care such as more diagnoses and more chronic conditions coded
After adjusting for scheduled visit duration and visit complexity, patients who were younger, publicly insured, Hispanic, and non-Hispanic Black had shorter visits
For each additional minute of a primary care visit, the probability of an inappropriate antibiotic prescription for upper respiratory tract infections decreased by 0.11 percentage points
For each additional minute of a primary care visit, the probability of coprescribing of opioids and benzodiazepines decreased by 0.01 percentage points
There was a statistically insignificant positive association of primary care visit length and potentially inappropriate prescribing among older adults (0.004 percentage points)
Shorter primary care visit length is associated with some inappropriate prescribing decisions and affects some patient groups disproportionately, the study's co-authors wrote.
"In this cross-sectional study of primary care physician visit length, shorter visit length was associated with higher rates of inappropriate antibiotic prescribing for upper respiratory tract infections and inappropriate coprescribing of opioids and benzodiazepines for patients with painful conditions, but similar patterns were not found for other potentially inappropriate prescribing decisions. We found considerable within-physician variation in visit length, with younger, publicly insured, Hispanic, and non-Hispanic Black patients receiving shorter visits. These findings suggest opportunities for additional research and operational improvements to visit scheduling and quality of prescribing decisions in primary care," they wrote.
Interpreting the data
With shorter visit length linked to some risk of lower-quality care, the researchers focused on patient and visit characteristics that were tied to time spent with the primary care physicians, the study's co-authors wrote. "Many of these associations suggest that patients with more medical complexity or with more to discuss received more time with their physicians, which may be expected. For example, visits that included more diagnoses—an imperfect proxy for number of topics discussed—were longer, as were visits for patients with more previously recorded chronic conditions and for new patients."
The researchers were troubled by links between patient-visit characteristics and visit time that were not readily explained by differences in patient clinical need, they wrote.
"For example, patients with Medicaid insurance coverage, dual Medicare and Medicaid coverage, or no insurance coverage received significantly shorter visits than commercially insured patients despite the latter population being healthier on average. Similarly, non-Hispanic Black patients received visits that were shorter, on average, than non-Hispanic White patients seeing the same physician. These visit-level differences may accumulate over time, potentially contributing to racial disparities in how much time patients spend with their physicians each year."
Increasing the length of patient visits for upper respiratory tract infections could improve antibiotic stewardship, the co-authors wrote. "Policy makers and health system leaders wishing to advance antibiotic stewardship best practices should take note of the association between visit length and inappropriate antibiotic prescribing. Our findings suggest that lengthening upper respiratory tract infection visits may be a promising strategy to lower inappropriate antibiotic prescribing, which has been a persistent population health concern for decades."
Patient safety has been a pressing issue in healthcare since 1999, with the publication of the landmark reportTo Err Is Human: Building a Safer Health System. Despite two decades of attention, estimates of annual patient deaths due to medical errors have risen steadily to as many as 440,000 lives, a figure that was reported in the Journal of Patient Safety in 2013.
The Top 10 patient safety concerns of 2023 according to ECRI and the Institute for Safe Medication Practices are as follows:
1.Pediatric mental health crisis
Pediatric mental health has reached crisis proportions, Marcus Schabacker, MD, PhD, president and CEO of ECRI, said in a prepared statement. "Even before COVID-19, the impact of social media, gun violence, and other socioeconomic factors were causing elevated rates of depression and anxiety in children. The challenges caused by the pandemic turned a bad situation into a crisis. We're approaching a national public health emergency."
Children are now at increased risk for suicide, the new annual report says. "The increase in children experiencing extreme anxiety and depression has led to an increase in suicidal ideation, with more young people age 12 to 25 presenting to the emergency department (ED) for suspected suicide attempts. Although adolescent suicide attempts had decreased during spring 2020, the mean weekly number of ED visits for suspected suicide attempts among those age 12 to 17 was 22% higher in summer 2020 and 39% higher during winter 2021 compared with the corresponding periods in 2019."
2. Physical and verbal violence against healthcare staff
Only law enforcement and security personnel face more workplace violence than healthcare workers, according to the annual report.
The Joint Commission has made workplace violence against healthcare workers a top priority, the annual report says. "In January 2022, Joint Commission accreditation standards began requiring leadership to develop and enforce a workplace violence prevention program. Joint Commission also states that effective workplace violence programs encourage reporting incidences of threatening language and verbal abuse in addition to physical abuse."
3. Clinician needs in times of uncertainty surrounding maternal-fetal medicine
When the U.S. Supreme Court overturned Roe v. Wade, which made maternal-fetal medicine a matter of state law, the high court created uncertainty for clinicians and their patients, the annual report says. "Although some states with abortion bans allow abortions to save the life of or prevent harm to the pregnant patient, there is often little guidance on where the line is. If clinicians wait too long, patients may suffer serious harm."
4. Impact on clinicians expected to work outside their scope of practice and competencies
Healthcare organizations have legal and ethical obligations to make sure clinical staff work within their scope of practice and competencies, but these obligations are being tested in several ways, the annual report says. "Many healthcare workers are still asked to step outside these boundaries, especially during public health emergencies and other societal circumstances such as staff shortages and turnover, increased patient volume, supply chain disruption, and rural facility closings."
5.Delayed identification and treatment of sepsis
Timely diagnosis and treatment of sepsis, which is the leading cause of death in hospitals, is crucial, the annual report says. "Intravenous antimicrobials should be administered immediately—ideally within an hour of recognition—for patients with shock and possible sepsis and for patients with a high likelihood of sepsis (including those without shock). Antimicrobials should be administered within three hours for patients with possible sepsis without shock."
6.Consequences of poor care coordination for patients with complex medical conditions
Care coordination is pivotal for patients with complex needs such as multiple chronic conditions because they often face care fragmentation, higher healthcare utilization, and worse health outcomes than other patients, the annual report says. "Improved care coordination can help mitigate these patient safety risks and preventable errors associated with common coordination pitfalls, including interprofessional communication, interoperability of health information technology (IT), medication reconciliation, test tracking and follow-up, and care transitions."
7.Risks of not looking beyond the "five rights" to achieve medication safety
The "five rights" of medication safety are right patient, right drug, right dose, right route, and right time, but they are insufficient on their own, the annual report says. "Failure to back up the five rights with high-leverage strategies and actionable procedures—or to identify which system processes failed when medication errors occur—undercuts medication safety."
8.Medication errors resulting from inaccurate patient medication lists
Inaccurate patient medication lists often occur because a patient is no longer taking a drug or a drug is omitted from the list, and healthcare organizations should have a robust system in place to address the problem, the annual report says. "Multidisciplinary medication reconciliation teams should review current processes, identify gaps and opportunities for improvement, and lead process design and redesign within the healthcare facility or practice. Team members should include executive leadership, physician champions, pharmacists, discharge planners, IT personnel, and patient safety and quality staff."
9.Accidental administration of neuromuscular blocking agents
Neuromuscular blocking agents paralyze skeletal muscles during mechanical ventilation, and they can be deadly when administered to patients who are not on a ventilator. According to the annual report, there are several causes of accidental administration of these medications, including look-alike packaging, unlabeled and mislabeled syringes, syringe swaps, and residual drug left in intravenous tubing.
10.Preventable harm due to omitted care or treatment
According to the annual report, missed care has several negative consequences, including complications such as pressure injuries, increased length of stay, and decreased patient satisfaction. "Some of the most common predictors of missed care include inadequate staffing levels; increased workload; poor work environment; limited staff experience, education, or competency; lack of material resources; poor communication; poor care transitions; limited skills mix of staff on the unit; and lack of teamwork," the report says.
As the number of long COVID cases grows, healthcare providers need to learn more about these patients.
Long COVID patients experience increased risk for several cardiovascular conditions in the year after coronavirus infection, a new research article found.
Long COVID, also known as post-COVID-19 condition (PCC), is defined as having new, returning, or ongoing health issues more than four weeks after an initial infection, according to the Centers for Disease Control and Prevention. Symptoms that lead to a diagnosis of long COVID include fatigue, cough, loss of taste or smell, shortness of breath, neurocognitive difficulties, and depression.
The new research article, which was published by JAMA Health Forum, features data collected from 13,435 long COVID adult patients and a control group of 26,870 adults without COVID-19. The data was drawn from national commercial insurance claims along with laboratory results and mortality data from the Social Security Administration's Death Master File and Datavant Flatiron data.
The research article has several key findings:
The long COVID patients experienced increased healthcare utilization for cardiac arrhythmias (relative risk 2.35).
The long COVID patients experienced increased healthcare utilization for pulmonary embolism (relative risk 3.64).
The long COVID patients experienced increased healthcare utilization for ischemic stroke (relative risk 2.17).
The long COVID patients experienced increased healthcare utilization for coronary artery disease (relative risk 1.78).
The long COVID patients experienced increased healthcare utilization for heart failure (relative risk 1.97).
The long COVID patients experienced increased healthcare utilization for chronic obstructive pulmonary disease (relative risk 1.94).
The long COVID patients experienced increased healthcare utilization for asthma (relative risk 1.95).
Risks for these conditions were higher for long COVID patients who were hospitalized during the acute phase of coronavirus infection compared to long COVID patients who were not hospitalized.
The long COVID patients also experienced increased mortality, with 2.8% of long COVID patients dying compared to 1.2% of individuals in the control group. This translated to an excess death rate of 16.4 per 1,000 individuals.
The long COVID patients in the study were at significantly higher risk for adverse outcomes in the year after initial infection, the research article's co-authors wrote. "This case-control study leveraged a large commercial insurance database and found increased rates of adverse outcomes over a 1-year period for a PCC cohort surviving the acute phase of illness. The results indicate a need for continued monitoring for at-risk individuals, particularly in the area of cardiovascular and pulmonary management."
Interpreting the data
Even for adults who are not hospitalized, long COVID patients are at risk for serious conditions and mortality, the study's co-authors wrote.
"Based on published literature, the most common symptoms experienced by individuals with PCC include fatigue, headache, and attention disorder. While these symptoms are concerning, results from this study also indicated a statistically significant increased risk for a range of cardiovascular conditions as well as mortality. While these risks were heightened for individuals who experienced a more severe acute episode of COVID-19 (ie, requiring hospitalization), it is essential to note that most individuals (72.5%) in the cohort did not experience hospitalization during the acute phase."
As the number of long COVID cases grows, healthcare providers need to learn more about these patients, the study's co-authors wrote. "Gaining additional insight into the risks and trajectory of the disease is essential for clinicians caring for these individuals, especially a need for primary prevention for individuals at higher risk. At a health-systems level, it is also necessary to develop resources and guidance for individuals at risk for serious complications."
The study has significant implications, they wrote. "From a health policy perspective, these results also indicate a meaningful effect on future healthcare utilization, and even potential implications for labor force participation. Gaining knowledge on the scope and trajectory of PCC is relevant for policy makers, given the recent guidance by the US Department of Health and Human Services that classifies 'long COVID' as a disability if it substantially limits major life activities."